CAPTRUST Financial Advisors’s CERo Therapeutics CERO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-26
Closed -$537K 2387
2022
Q4
$537K Sell
26
-1
-4% -$20.6K ﹤0.01% 1294
2022
Q3
$540K Buy
+27
New +$540K ﹤0.01% 1207